And there’s very little bidding on drugs,” Trump said during the event at Trump Tower in New York.
But public anger about drug prices remains a vulnerability, he added.
Saunders has been outspoken that drug companies should show restraint in pricing to avoid a government intervention that could stifle the industry.
But do Trump and Republicans have the guts to police drug companies and lower prices?
“The fiscal and tax policies are going to make a difference here.”More from Wonkblog:Drugmakers question the future of drug prices under Trump